Novavax, Inc. (LON:0A3S)
London · Delayed Price · Currency is GBP · Price in USD 6.71
+0.04 (0.55%)
At close: Dec 19, 2025
Novavax Market Cap
Novavax has a market cap or net worth of 809.2 million as of December 19, 2025. Its market cap has decreased by -22.61% in one year.
Market Cap
809.20M
Enterprise Value
426.56M
Revenue
792.04M
Ranking
n/a
PE Ratio
3.18
Stock Price
6.71
Market Cap Chart
Since July 25, 1996, Novavax's market cap has increased from 22.60M to 809.20M, an increase of 3,480.58%. That is a compound annual growth rate of 12.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 809.20M | -21.34% |
| Dec 31, 2024 | 1.03B | 129.81% |
| Dec 29, 2023 | 447.65M | -38.98% |
| Dec 30, 2022 | 733.56M | -90.82% |
| Dec 31, 2021 | 7.99B | 167.41% |
| Dec 31, 2020 | 2.99B | 4,139.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.02B |
| HSBC Holdings | 200.10B |
| Shell | 154.83B |
| Unilever | 108.28B |
| Rio Tinto Group | 99.46B |
| Rolls-Royce Holdings | 97.94B |
| British American Tobacco p.l.c. | 92.05B |
| GSK plc | 73.11B |